Advertisement

week in cancer news

  • September 16: The Week In Cancer News

    Air pollution research provides clues to how cancer starts, and KRAS-targeting drug appears to keep cancer at bay longer than standard of care, but questions remain

    by Marci A. Landsmann

  • September 9: The Week in Cancer News

    Early-onset cancer is increasing globally, and testing population-wide preventive DNA testing.

    by Kevin McLaughlin

  • September 2: The Week in Cancer News

    Fertility preservation does not impact outcomes for breast cancer patients, and ultraprocessed foods linked to increased risk of colorectal cancer in men.

    by Thomas Celona

  • August 26: The Week in Cancer News

    Advanced cervical cancer rates are rising despite prevention and screening tools, and CAR T-cell therapy inaccessible to many across the country.

    by Eric Fitzsimmons

  • August 19: The Week in Cancer News

    Link found between fracking wells and leukemia in children, and accurate reporting of cancer outcomes urged for Native Hawaiians and Pacific Islanders.

    by Kevin McLaughlin

  • August 12: The Week in Cancer News

    Drug for HER2-positive cancer receives further approvals, and researchers study the risk of lung cancer from wildfires.

    by Marci A. Landsmann

  • August 5: The Week in Cancer News

    Study finds majority of patients treated with chemotherapy experience hearing loss, and ‘rogue’ online pharmacies found to be dispensing oncology drugs.

    by Thomas Celona

  • July 29: The Week in Cancer News

    Cancer patients and doctors concerned about how abortion bans will affect treatment, and resistant starch supplements lower risk of many cancers in people with Lynch syndrome.

    by Eric Fitzsimmons

  • July 22: The Week in Cancer News

    Drug shortages in hematology oncology, and cancer centers don’t accept Medicaid.

    by Marci A. Landsmann

  • July 15: The Week in Cancer News

    COVID-19 boosters promote immune response in additional blood cancer patients, and high drug costs lead cancer patients to not fill prescriptions.

    by Kevin McLaughlin